Inverness Medical Innovations (IMA) Posts Q3 EPS of $0.74
Inverness Medical Innovations Inc. (NYSE: IMA) reports Q3 EPS of $0.74, versus the analyst estimate of $0.61. Revenue for the quarter was $ million, which compares to the estimate of $491.73 million.
You May Also Be Interested In
- UPDATE: Youku.com (YOKU) Misses Q1 EPS by 1c; Sees Q2 Sales Up 90-100% YoY
- UPDATE: Stein Mart (SMRT) Reports Q1 Adj-EPS of 32c, Beats by 2c
- Donaldson Co., Inc. (DCI) Tops Q3 EPS by 3c; Narrows FY12 Revs Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
